All posts by: Michael Zand

About Michael Zand

Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress – DigitalJournal.com

Neuralstem CEO To Present At Stem Cells & Regenerative Medicine CongressDigitalJournal.comROCKVILLE, Md., Sept. 26, 2013 /PRNewswire/ — Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO, Richard Garr, will present at the Stem Cells & Regenerative Medicine Congress, on Monday, September 30 at 12:00 PM at the Hyatt … …read more   &nbs… Continue reading

2013-09-26 NEWS

Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress – PR Newswire (press release)

Neuralstem CEO To Present At Stem Cells & Regenerative Medicine CongressPR Newswire (press release)ROCKVILLE, Md., Sept. 26, 2013 /PRNewswire/ — Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO, Richard Garr, will present at the Stem Cells & Regenerative Medicine Congress, on Monday, September 30 at 12:00 PM at the Hyatt … …read more   &nbs… Continue reading

2013-09-26 NEWS

Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress – MarketWatch (press release)

Neuralstem CEO To Present At Stem Cells & Regenerative Medicine CongressMarketWatch (press release)ROCKVILLE, Md., Sept. 26, 2013 /PRNewswire via COMTEX/ — Neuralstem, Inc. (nyse mkt:CUR) announced that President and CEO, Richard Garr, will present at the Stem Cells & Regenerative Medicine Congress, on Monday, September 30 at 12:00 PM at … …read more   &nbs… Continue reading

2013-09-26 NEWS

New Brain Cancer Treatment Targets Stem Cells And Tackles Tumour Growth – Huffington Post UK

New Brain Cancer Treatment Targets Stem Cells And Tackles Tumour GrowthHuffington Post UKA new experimental approach to treating a type of brain cancer has been developed by researchers. Medulloblastoma targets cancer stem cells – critical for maintaining tumour growth – and halts their ability to proliferate by inhibiting enzymes … …read more   &nbs… Continue reading

2013-09-26 NEWS